Literature DB >> 516310

Respiratory and cardiac arrest under general anaesthesia: treatment by acupuncture of the nasal philtrum.

L Janssens, S Altman, P A Rogers.   

Abstract

The philtrum point VG 26 (Jen Chung) was needled in 69 cases of respiratory depression or apnoea in dogs and cats during induction or maintenance of general anaesthesia. Respiration was restored to normal or near normal rates within 10 to 30 seconds of insertion of the needle in all the cases. In seven cases of anaesthetic apnoea with concurrent cardiac arrest and absence of vital signs, the revival rate was 43 per cent. Those which recovered required four to 10 minutes of acupuncture stimulation. In eight cases of collapse due to other causes, the revival rate was 25 per cent. The cases included five sheep in shock following liver biopsy, two cases of haemorrhagic shock (dog, cat) and one terminal collapse in chronic congestive heart failure (dog).

Entities:  

Mesh:

Year:  1979        PMID: 516310     DOI: 10.1136/vr.105.12.273

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  4 in total

Review 1.  Spotlight on acupuncture in laboratory animal medicine.

Authors:  Elizabeth R Magden
Journal:  Vet Med (Auckl)       Date:  2017-08-24

Review 2.  Veterinary acutherapy in management of musculoskeletal disorders: An eye-opener to the developing countries' veterinarians.

Authors:  Olawale Alimi Alimi; Adamu Abdul Abubakar; Abubakar Sadiq Yakubu; Abdullahi Aliyu; Salman Zubairu Abulkadir
Journal:  Open Vet J       Date:  2020-07-29

3.  Acupuncture effects on cardiac functions measured by cardiac magnetic resonance imaging in a feline model.

Authors:  Jen-Hsou Lin; Chen-Haw Shih; Krishna Kaphle; Leang-Shin Wu; Weng-Yih Tseng; Jen-Hwey Chiu; Tzu-Chi Lee; Ying-Ling Wu
Journal:  Evid Based Complement Alternat Med       Date:  2008-01-23       Impact factor: 2.629

4.  Ten Years Evidence-based High-Tech Acupuncture Part 3: A Short Review of Animal Experiments.

Authors:  Gerhard Litscher
Journal:  Evid Based Complement Alternat Med       Date:  2008-11-05       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.